Hodgkins Lymphoma

KEYNOTE trials demonstrate Keytruda immunotherapy is highly effective treatment of advanced-refractory Hodgkin Lymphoma

Adcetris + AVD and G-CSF significantly improves outcomes compared to ABVD - 4 years follow up.from ASH 2019.

Treatment consists of high dose chemotherapy, stem cell transplant, CAR T cells and precision cancer medicines.

Caring for Yourself During Chemotherapy for Hodgkin’s Lymphoma: How to Manage Hair Loss, Dry Skin, and Brittle Nails

HL: Be aware of longer term complications and issues.

HL survivors at increased risk of developing new cancers and other long term side effects.

PD-1 Immunotherapy gaining traction in HL - ASH 2019 data demonstrates effectives as "Bridge" to ASCT.